Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:35 UTC |
---|
HMDB ID | HMDB0014351 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Reserpine |
---|
Description | Reserpine, also known as apoplon or serpalan, belongs to the class of organic compounds known as yohimbine alkaloids. These are alkaloids containing the pentacyclic yohimban skeleton. The Yohimbinoid alkaloids contain a carbocyclic ring E arising through C-17 to C-18 bond formation in a corynantheine precursor. Reserpine is a very strong basic compound (based on its pKa). Reserpine is a potentially toxic compound. An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. |
---|
Structure | [H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2 InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Reserpine | ChEBI | (3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester | ChEBI | 3,4,5-Trimethoxybenzoyl methyl reserpate | ChEBI | Apoplon | ChEBI | Reserpin | ChEBI | Serpalan | ChEBI | (3b,16b,17a,18b,20a)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate methyl ester | Generator | (3b,16b,17a,18b,20a)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester | Generator | (3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate methyl ester | Generator | (3Β,16β,17α,18β,20α)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate methyl ester | Generator | (3Β,16β,17α,18β,20α)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester | Generator | 3,4,5-Trimethoxybenzoyl methyl reserpic acid | Generator | Rausedil | HMDB | Serpasil | HMDB | V Serp | HMDB | V-Serp | HMDB | Raupasil | HMDB | Serpivite | HMDB | Raunervil | HMDB | Vitarine brand OF reserpine | HMDB | Rausedyl | HMDB | Vangarde brand OF reserpine | HMDB |
| Show more...
---|
Chemical Formula | C33H40N2O9 |
---|
Average Molecular Weight | 608.6787 |
---|
Monoisotopic Molecular Weight | 608.273380888 |
---|
IUPAC Name | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
---|
Traditional Name | reserpine |
---|
CAS Registry Number | 50-55-5 |
---|
SMILES | [H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2 |
---|
InChI Identifier | InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1 |
---|
InChI Key | QEVHRUUCFGRFIF-MDEJGZGSSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as yohimbine alkaloids. These are alkaloids containing the pentacyclic yohimban skeleton. The Yohimbinoid alkaloids contain a carbocyclic ring E arising through C-17 to C-18 bond formation in a corynantheine precursor. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Yohimbine alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Yohimbine alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Yohimbine
- Corynanthean skeleton
- Yohimbine alkaloid
- Pyridoindole
- Beta-carboline
- Gallic acid or derivatives
- P-methoxybenzoic acid or derivatives
- M-methoxybenzoic acid or derivatives
- Benzoate ester
- 3-alkylindole
- Indole
- Indole or derivatives
- Benzoic acid or derivatives
- Benzoyl
- Phenol ether
- Anisole
- Phenoxy compound
- Methoxybenzene
- Alkyl aryl ether
- Aralkylamine
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Piperidine
- Pyrrole
- Methyl ester
- Heteroaromatic compound
- Tertiary aliphatic amine
- Amino acid or derivatives
- Tertiary amine
- Carboxylic acid ester
- Organoheterocyclic compound
- Ether
- Carboxylic acid derivative
- Azacycle
- Dialkyl ether
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 264.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.011 g/L | Not Available | LogP | 3.2 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M-H]- | McLean | 266.49 | 30932474 | [M+H]+ | McLean | 252.18 | 30932474 |
|
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Reserpine,1TMS,isomer #1 | COC(=O)[C@H]1[C@H]2C[C@@H]3C4=C(CCN3C[C@H]2C[C@@H](OC(=O)C2=CC(OC)=C(OC)C(OC)=C2)[C@@H]1OC)C1=CC=C(OC)C=C1N4[Si](C)(C)C | 4595.6 | Semi standard non polar | 33892256 | Reserpine,1TMS,isomer #1 | COC(=O)[C@H]1[C@H]2C[C@@H]3C4=C(CCN3C[C@H]2C[C@@H](OC(=O)C2=CC(OC)=C(OC)C(OC)=C2)[C@@H]1OC)C1=CC=C(OC)C=C1N4[Si](C)(C)C | 4482.4 | Standard non polar | 33892256 | Reserpine,1TMS,isomer #1 | COC(=O)[C@H]1[C@H]2C[C@@H]3C4=C(CCN3C[C@H]2C[C@@H](OC(=O)C2=CC(OC)=C(OC)C(OC)=C2)[C@@H]1OC)C1=CC=C(OC)C=C1N4[Si](C)(C)C | 6436.0 | Standard polar | 33892256 | Reserpine,1TBDMS,isomer #1 | COC(=O)[C@H]1[C@H]2C[C@@H]3C4=C(CCN3C[C@H]2C[C@@H](OC(=O)C2=CC(OC)=C(OC)C(OC)=C2)[C@@H]1OC)C1=CC=C(OC)C=C1N4[Si](C)(C)C(C)(C)C | 4733.0 | Semi standard non polar | 33892256 | Reserpine,1TBDMS,isomer #1 | COC(=O)[C@H]1[C@H]2C[C@@H]3C4=C(CCN3C[C@H]2C[C@@H](OC(=O)C2=CC(OC)=C(OC)C(OC)=C2)[C@@H]1OC)C1=CC=C(OC)C=C1N4[Si](C)(C)C(C)(C)C | 4638.7 | Standard non polar | 33892256 | Reserpine,1TBDMS,isomer #1 | COC(=O)[C@H]1[C@H]2C[C@@H]3C4=C(CCN3C[C@H]2C[C@@H](OC(=O)C2=CC(OC)=C(OC)C(OC)=C2)[C@@H]1OC)C1=CC=C(OC)C=C1N4[Si](C)(C)C(C)(C)C | 6367.6 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Reserpine EI-B (Non-derivatized) | splash10-052b-0944108000-d2416a07c507dd693e2b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Reserpine EI-B (Non-derivatized) | splash10-052b-0944108000-d2416a07c507dd693e2b | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Reserpine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-0549060000-793104ae04e257941689 | 2017-09-01 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0002-2943000000-8f7998aa667566277f3f | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine Linear Ion Trap , negative-QTOF | splash10-0006-0000090000-a4f3a4e74644a66e8705 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine Linear Ion Trap , negative-QTOF | splash10-0006-0000090000-22aa398156f73127b459 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine Linear Ion Trap , negative-QTOF | splash10-0006-0000090000-1a35ce10a9657b978845 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine Linear Ion Trap , negative-QTOF | splash10-0006-0000090000-f1a507980fe5d4bc47a4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-0002-0108920000-d8cec36e08efb0c1e16e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-0a4i-0000009000-2bafaa3238dfda9f4989 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-0002-0916102000-d591ae99a68ca35e63b7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-006t-0911000000-1cb6207a1835b7efb13a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-00dj-0910000000-550f1f23f96cefe74849 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-05gi-1910000000-9dd2d1b6087fe8b9d1c9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-001i-1910000000-7038e3a2f74fff79f220 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-0a4i-0000009000-ea7c0832701dc10b3266 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-0002-0916103000-b1128c59f469bc4d949f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-006t-0911000000-8109e56a0558f3f60659 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-00dj-0910000000-c3773763c7f72b03b234 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-05gi-1910000000-21728d59759dc657e49b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-001i-1910000000-bf727df9cb8b3d8296a0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-ITFT , positive-QTOF | splash10-0002-0108920000-29c40cb6bef71c53750f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Reserpine LC-ESI-QTOF , positive-QTOF | splash10-0a4i-0000009000-0004d3aa672941e611c5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reserpine 10V, Positive-QTOF | splash10-0a4i-0004069000-dbc0a3b6edf66c8683bd | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reserpine 20V, Positive-QTOF | splash10-054k-0205093000-0c6931938051f0e1a721 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reserpine 40V, Positive-QTOF | splash10-066r-6438290000-e3ef63fc93c29206b47c | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reserpine 10V, Negative-QTOF | splash10-0a4i-0120029000-1e1e860a71102dcc5e5b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reserpine 20V, Negative-QTOF | splash10-092c-0321092000-7fe3c97e8909b5c37599 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reserpine 40V, Negative-QTOF | splash10-01t9-2940040000-c9fe57795b1118e171f4 | 2016-08-03 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00206 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00206 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00206 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | C00001763 |
---|
Chemspider ID | 5566 |
---|
KEGG Compound ID | C06539 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Reserpine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5770 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 28487 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Authors unspecified: Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979 Dec 7;242(23):2562-71. [PubMed:490882 ]
- Authors unspecified: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991 Jun 26;265(24):3255-64. [PubMed:2046107 ]
- Moser M: "Cost containment" in the management of hypertension. Ann Intern Med. 1987 Jul;107(1):107-9. [PubMed:3592424 ]
- Authors unspecified: Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967 Dec 11;202(11):1028-34. [PubMed:4862069 ]
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. Epub 2003 May 14. [PubMed:12748199 ]
|
---|